iplex gold assay (maldi-tof mass spectrometry, massarray analyzer compact) (Sequenom)
90
Structured Review
Sequenom
iplex gold assay (maldi-tof mass spectrometry, massarray analyzer compact)
Iplex Gold Assay (Maldi Tof Mass Spectrometry, Massarray Analyzer Compact), supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/iplex+gold+assay+(maldi-tof+mass+spectrometry%2C+massarray+analyzer+compact)/iplex+assay/pmc03119024-172-8-18
Average 90 stars, based on 1 article reviews
Iplex Gold Assay (Maldi Tof Mass Spectrometry, Massarray Analyzer Compact), supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/iplex+gold+assay+(maldi-tof+mass+spectrometry%2C+massarray+analyzer+compact)/iplex+assay/pmc03119024-172-8-18
Average 90 stars, based on 1 article reviews
iplex gold assay (maldi-tof mass spectrometry, massarray analyzer compact) - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Iplex Gold Assay:Article Title: Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population Article Snippet: .. Genotyping KCNQ1 G589D, KCNQ1 IVS7-2A>G (c.1129-2A>G), KCNH2 L552S, PKP2 Q59L, PKP2 Q62K, PKP2 N613K, DSG2 3059_3062delAGAG, DSP T1373A, and RYR2 R3570W were genotyped in genomic DNA of all study subjects using the Article Title: Prevalence and clinical correlates of familial hypercholesterolemia founder mutations in the general population. Article Snippet: Objective: This study aimed to investigate the exact prevalence of familial hypercholesterolemia (FH) in the general population, taking advantage of the fact that five low-density lipoprotein receptor (LDLR) founder mutations account for 78% of FH cases in Finland.. Methods: Five LDLR founder mutations, FHNorth Karelia, FH-Helsinki, FH-Pogosta, FH-Turku, and FH-Pori, were genotyped and serum lipid levels were measured in a large collection of Finnish population cohorts (n 1⁄4 28,465), including the National FINRISK Study and the Health 2000 Study.. Follow-up data were obtained from national healthcare registries. Article Title: Common Genetic Variants, QT Interval and Sudden Cardiac Death in a Finnish Population-Based Study Article Snippet: .. Genotyping of genomic DNA was performed using the Article Title: Identification of a KCNQ1 Polymorphism Acting as a Protective Modifier against Arrhythmic Risk in Long QT Syndrome Article Snippet: In the SA-LQT1 population, polymorphisms were genotyped by Taqman assay on 7900 HT Fast Real Time PCR System (Applied Biosystem) and in a subset of samples direct sequencing was performed as well, with the same results. .. In the Finnish LQT1 population, genotyping was performed using the Article Title: Common genetic variants associated with sudden cardiac death: the FinSCDgen study. Article Snippet: .. Genomic DNA was genotyped using the Mass Spectrometry:Article Title: Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population Article Snippet: .. Genotyping KCNQ1 G589D, KCNQ1 IVS7-2A>G (c.1129-2A>G), KCNH2 L552S, PKP2 Q59L, PKP2 Q62K, PKP2 N613K, DSG2 3059_3062delAGAG, DSP T1373A, and RYR2 R3570W were genotyped in genomic DNA of all study subjects using the Article Title: Prevalence and clinical correlates of familial hypercholesterolemia founder mutations in the general population. Article Snippet: Objective: This study aimed to investigate the exact prevalence of familial hypercholesterolemia (FH) in the general population, taking advantage of the fact that five low-density lipoprotein receptor (LDLR) founder mutations account for 78% of FH cases in Finland.. Methods: Five LDLR founder mutations, FHNorth Karelia, FH-Helsinki, FH-Pogosta, FH-Turku, and FH-Pori, were genotyped and serum lipid levels were measured in a large collection of Finnish population cohorts (n 1⁄4 28,465), including the National FINRISK Study and the Health 2000 Study.. Follow-up data were obtained from national healthcare registries. Article Title: Common Genetic Variants, QT Interval and Sudden Cardiac Death in a Finnish Population-Based Study Article Snippet: .. Genotyping of genomic DNA was performed using the Article Title: Identification of a KCNQ1 Polymorphism Acting as a Protective Modifier against Arrhythmic Risk in Long QT Syndrome Article Snippet: In the SA-LQT1 population, polymorphisms were genotyped by Taqman assay on 7900 HT Fast Real Time PCR System (Applied Biosystem) and in a subset of samples direct sequencing was performed as well, with the same results. .. In the Finnish LQT1 population, genotyping was performed using the Article Title: Common genetic variants associated with sudden cardiac death: the FinSCDgen study. Article Snippet: .. Genomic DNA was genotyped using the other:Article Title: Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population Article Snippet: KCNQ1 G589D, KCNQ1 IVS7-2A>G (c.1129-2A>G), KCNH2 L552S, PKP2 Q59L, PKP2 Q62K, PKP2 N613K, DSG2 3059_3062delAGAG, DSP T1373A, and RYR2 R3570W were genotyped in genomic DNA of all study subjects using the Article Title: Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population. Article Snippet: KCNQ1 G589D, KCNQ1 IVS7-2A G (c.1129-2A G), KCNH2 L552S, PKP2 Q59L, PKP2 Q62K, PKP2 N613K, DSG2 3059_3062delAGAG, DSP T1373A, and RYR2 R3570W were genotyped in genomic DNA of all study subjects using the |